Medtronic MiniMed 600 Series Insulin Pump Recall
Did You or a Loved One Experience Problems with a Medtronic MiniMed 600 Series Insulin Pump? The Attorneys at Miller Weisbrod Olesky Can Help!
Medtronic's defective insulin pumps have put thousands of people at risk of serious injury or death. If you or a loved one has been affected, call Miller Weisbrod Olesky's Insulin Pump Attorneys today.
Design defects and manufacturing problems with the Medtronic MiniMed 630G and 670G pumps have been linked to serious and potentially life-threatening complications:
- Hypoglycemia
- Hyperglycemia
- Seizures
- Diabetic Ketoacidosis
- Coma
- Wrongful Death
Contact the 2021 US News' Best Law Firm, Miller Weisbrod Olesky - Attorneys at Law, to learn more and find out of financial compensation may be available through a Medtronic MiniMed recall settlement.
What is a Medtronic MiniMed insulin pump
The Medtronic MiniMed insulin pumps are small, computerized devices that deliver insulin to diabetic patients throughout the day, via a catheter implanted under the skin. They are wirelessly connected to both the patient’s blood glucose meter and a monitoring system to track glucose levels, as well as a remote controller that is designed to communicate with the pump and deliver a specific amount of insulin.
Medtronic sent to customers in November 2019, after discovering that certain pumps may have a missing or broken retainer ring, which could result in the over or under delivery of insulin. The FDA later declared the Medtronic letter to be a Class I medical device recall, which is the most serious recall classification, and indicates that problems with a device could result in serious injury or death.
The FDA announced the Medtronic MiniMed 600 series insulin pump recall on February 12, which impacted more than 300,000 insulin pumps distributed since September 2016. To date, Medtronic has become aware of at least 26,421 complaints in which the insulin pump over or under delivered the programmed amount of insulin, resulting in 2,175 injuries and at least one death.
Customers in the United States (U.S.) can determine if they have recalled infusion sets by visiting the following link: Medtronic MiniMed 600 Recall Notice.
Medtronic's History Of Pump Failures
September 2017:
The FDA announced the Medtronic MiniMed infusion pump recall following reports of consumers suffering from hypoglycemia caused by over delivery of insulin. The issue was related to a component of the device called a vent membrane, which can be blocked by fluid. Medtronic discontinued the use of the vent membrane component in April 2017.
September 2014:
Medtronic issued a MiniMed Paradigm insulin pump recall for more than half a million units following reports that programming errors led to patients receiving the wrong dose of insulin. At least one report of hypoglycemia was linked to the problem, which caused some users to accidentally give themselves the maximum insulin dose.
June 2013:
The company issued a MiniMed Paradigm infusion set recall because fluid could get into vents, preventing the pump from priming properly, which could cause severe or even fatal health problems for diabetics. It was one of four recalls or urgent device notifications involving Medtronic’s insulin pumps that year alone.
2009:
Medtronic Inc. issued a similar recall for approximately three million Quick-set infusion sets used with its MiniMed Paradigm insulin pumps, due to a manufacturing defect that could result in the delivery of incorrect doses of insulin and cause injury or death for diabetics.
Following these recalls, a number of Medtronic Insulin Pump lawsuits were filed on behalf of patients that suffered serious injury or death when they received an Overdose or Under-dose of insulin.
Contact Miller Weisbrod Olesky
To determine whether you are eligible to submit a claim, please call our Dallas office at 214.987.0005 to discuss your situation with an experienced drug litigation attorney. If you are calling from outside the DFW Metroplex, please call us toll free at 888.987.0005.